High‐fat Diets: Modeling the Metabolic Disorders of Human Obesity in Rodents

Obesity - Tập 15 Số 4 - Trang 798-808 - 2007
Roland Buettner1, Jürgen Schölmerich1, Cornelius Bollheimer1
1Dept. of Internal Medicine I, University of Regensburg, Regensburg, Germany.

Tóm tắt

Abstract

Research Methods and Procedures: High‐fat (HF) diet feeding can induce obesity and metabolic disorders in rodents that resemble the human metabolic syndrome. However, this dietary intervention is not standardized, and the HF‐induced phenotype varies distinctly among different studies. The question which HF diet type is best to model the metabolic deterioration seen in human obesity remains unclear. Therefore, in this review, metabolic data obtained with different HF diet approaches are compiled. Both whole‐body and organ‐specific diet effects are analyzed.

Results: On the basis of these results, we conclude that animal fats and ω‐6/ω‐9‐containing plant oils can be used to generate an obese and insulin‐resistant phenotype in rodents, whereas fish oil‐fed animals do not develop these disorders.

Discussion: Looking at the present data, it does not seem possible to define an ideal HF diet, and an exact definition of diet composition and a thorough metabolic characterization of the HF diet effects in a researcher's specific laboratory setting remains essential for metabolic studies with this model.

Từ khóa


Tài liệu tham khảo

10.2337/diab.46.11.1768

10.1097/00006676-199901000-00010

10.1016/S1471-4914(02)02377-8

10.1210/endo-31-1-42

Samuels L. T., 1948, The effect of previous diet on the ability of animals to do work during subsequent fasting, J Nutr., 36, 639, 10.1093/jn/36.5.639

Budohoski L., 1993, Effects of saturated and polyunsaturated fat enriched diet on the skeletal muscle insulin sensitivity in young rats, J Physiol Pharmacol., 44, 391

Harris R. B., 1992, Insulin insensitivity is rapidly reversed in rats by reducing dietary fat from 40 to 30% of energy, J Nutr., 122, 1811, 10.1093/jn/122.9.1811

Peckham S. C., 1962, The influence of a hypercaloric diet on gross body and adipose tissue composition in the rat, J Nutr., 77, 187, 10.1093/jn/77.2.187

10.1097/00041433-200204000-00007

10.1074/jbc.R000015200

10.1152/ajpregu.00675.2004

10.1016/j.peptides.2004.08.009

10.1038/oby.2003.116

10.1126/science.3303333

10.1007/BF00418533

Storlien L. H., 2000, Diet composition and insulin action in animal models, Br J Nutr., 83, S85, 10.1017/S0007114500001008

10.1111/j.1749-6632.2002.tb04288.x

Storlien L. H., 1991, Influence of dietary fat composition on development of insulin resistance in rats: relationship to muscle triglyceride and omega‐3 fatty acids in muscle phospholipid, Diabetes, 40, 280, 10.2337/diab.40.2.280

10.1016/S0026-0495(96)90185-7

10.1152/jappl.2001.91.5.2240

10.2337/diab.37.9.1163

10.1016/S0026-0495(98)90037-3

10.1152/ajpendo.00173.2001

Okada S., 1992, Differential inhibition of fat intake in two strains of rat by the peptide enterostatin, Am J Physiol., 262, R1111

10.3181/00379727-149-38915

10.1038/oby.2002.161

10.1038/oby.2000.58

Fisler J. S., 1984, Catecholamine turnover in S 5B/P1 and Osborne‐Mendel rats: response to a high‐fat diet, Am J Physiol., 247, R290

10.1152/ajpregu.00162.2004

10.1038/sj.ijo.0803110

10.1016/j.brainres.2005.03.047

10.1152/ajpregu.2000.278.4.R797

10.1016/0026-0495(95)90123-X

10.1152/ajpendo.1998.274.6.E1057

West D. B., 1992, Dietary obesity in nine inbred mouse strains, Am J Physiol., 262, R1025

West D. B., 1995, Dietary obesity in the mouse: interaction of strain with diet composition, Am J Physiol., 268, R658

10.1093/ajcn/67.3.505S

Smith B. K., 1997, Carbohydrate versus fat intake: differing patterns of macronutrient selection in two inbred mouse strains, Am J Physiol., 272, R357

Smith B. K., 1999, Divergence in proportional fat intake in AKR/J and SWR/J mice endures across diet paradigms, Am J Physiol., 277, R776

10.1016/j.physbeh.2004.02.006

10.1677/joe.1.06333

10.1210/en.2002-220835

10.1055/s-2002-38251

10.2337/diabetes.53.12.3274

Luo J., 1996, Dietary (n‐3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin‐resistant rats: relation to membrane fatty acids, J Nutr., 126, 1951

10.1007/BF02535161

10.1016/0005-2760(91)90297-U

10.1074/jbc.274.36.25892

10.2337/diabetes.31.3.232

10.1152/ajpendo.00320.2001

10.2337/diab.46.2.215

10.1074/jbc.273.40.26157

10.2337/diabetes.50.1.123

10.1079/BJN2003000968

10.1152/ajpendo.2000.278.3.E563

10.1038/80450

10.1007/s00125-003-1272-8

10.1172/JCI0214596

10.1172/JCI200418917

10.1042/bj2990831

10.1093/jn/123.3.512

10.2337/diabetes.53.6.1412

10.1152/ajpcell.1993.264.5.C1111

Corbett S. W., 1986, Energy expenditure in rats with diet‐induced obesity, Am J Clin Nutr., 44, 173, 10.1093/ajcn/44.2.173

Tepperman H. M., 1986, Effect of a high fat diet on rat adipocyte lipolysis: responses to epinephrine, forskolin, methylisobutylxanthine, dibutyryl cyclic AMP, insulin and nicotinic acid, J Nutr., 116, 1984, 10.1093/jn/116.10.1984

10.1016/S0014-5793(97)01381-1

10.1210/en.2003-0456

10.1159/000012772

Lavau M., 1979, Mechanism of insulin resistance in adipocytes of rats fed a high‐fat diet, J Lipid Res., 20, 8, 10.1016/S0022-2275(20)40645-5

Maegawa H., 1986, Effect of diet change on insulin action: difference between muscles and adipocytes, Am J Physiol., 251, E616

10.1152/ajpendo.1986.251.5.E576

10.2337/diabetes.37.10.1397

10.2337/diabetes.48.8.1662

10.1111/j.1749-6632.1993.tb35712.x

10.1111/j.1749-6632.1993.tb35696.x

10.2337/diabetes.53.4.931

10.1210/en.2003-1674

10.1210/en.2004-1063

10.2337/diabetes.51.11.3189

10.1152/ajpendo.00259.2003

10.1016/1357-2725(94)00065-J

10.1053/bega.2002.0325

10.2337/diabetes.54.2.322

10.2337/diabetes.48.1.158

10.1152/ajpendo.00453.2003

10.2337/diabetes.51.2.271

10.1038/90992

10.1016/0026-0495(87)90051-5

10.1152/ajpendo.00332.2002

10.1074/jbc.273.47.31160

10.1038/nm1166

10.1172/JCI420

10.1677/jme.0.0310061

10.2337/diab.44.8.863

10.2337/diabetes.52.8.2057

10.1152/ajpendo.00199.2002

10.1016/S0026-0495(97)90175-X

10.1210/en.2003-0479

10.1152/ajpregu.00335.2004

10.1152/ajpendo.2001.280.1.E130

10.2337/diabetes.51.3.662

10.1093/jn/134.11.2979

10.1093/jn/133.4.1081

10.1093/jn/127.4.566

10.1002/hep.20093

10.1152/ajpendo.00072.2001

10.1152/ajpendo.2001.281.2.E275

10.1152/ajpendo.00320.2001

10.1016/S0168-8278(02)00212-X

10.1210/en.2003-1015

10.1152/ajpendo.00299.2002

10.1152/ajpendo.00184.2004